Gyre Therapeutics (GYRE) traded down -0.17 % during a 24 hours period ending at 03:21 PM Central Europe on Monday 26th. One Gyre Therapeutics stock can currently be bought for about USD 6 on popular exchanges. Current supply of Gyre Therapeutics stocks is 106 mn. Gyre Therapeutics has a current market capitalization of USD 620.3 mn and approximately USD 886.3 k worth of Gyre Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Gyre Therapeutics has traded -20.19 % down. Simple moving average of last 200 days is at USD 7.02. The highest price of past 52 weeks was recorded at USD 9.14 on 03/05/2026. 52 weeks low was at USD 5.44 on 06/02/2026.
Here is how related stocks have performed in the past 24 hours:
Yext (YEXT) traded up 0.14 % and now trades at USD 7.33. Yext has a market capitalisation of USD 727.5 mn. Current price/earnings ratio for Yext is 44.41.
Par /Del (PAR) traded down -1.76 % and now trades at USD 17.65. Current market capitalisation for Par /Del is USD 738.3 mn.
Profrac (ACDC) traded up 5.44 % and now trades at USD 4.18. Profrac has a market capitalisation of USD 741.2 mn.
Lsi Industries (LYTS) traded up 1.71 % and now trades at USD 20.7. Current market capitalisation for Lsi Industries is USD 733.3 mn. Lsi Industries has a current price to earnings ratio of 30.09.
About Gyre Therapeutics
Gyre Therapeutics, Inc. is a bio-pharmaceutical company that specializes in the development and commercialization of hydronidone (F351) for the treatment of metabolic dysfunction associated steatohepatitis.
